Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 58 Results

Intervention Indication Therapeutic Area Year Actions
Budesonide granules for induction of remission in lymphocytic colitis – first line Budesonide gastro-resistant (Budenofalk) Lymphocytic colitis Gastroenterology , Immunology 2020 View  |  Download
Canakinumab for Schnitzler syndrome Canakinumab (Ilaris; ACZ885) Schnitzler syndrome Immunology 2021 View  |  Download
Clobetasol propionate for postoperative pain and inflammation associated with cataract surgery Clobetasol propionate ophthalmic nanoemulsion (SVT-15473) Post-operative inflammation , Post-operative pain Immunology , Pain Relief 2020 View  |  Download
CTX001 for severe sickle cell disease CTX001 Leukocyte adhesion deficiency , Sickle cell disease (SCD) Haematology , Immunology 2021 View  |  Download
Dupilumab for eosinophilic oesophagitis in paediatric patients Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Eosinophilic oesophagitis Gastroenterology , Immunology 2023 View  |  Download
Dupilumab for treating eosinophilic oesophagitis in people aged 12 years and older Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Eosinophilic oesophagitis Gastroenterology , Immunology 2022 View  |  Download
Emapalumab for Primary Haemophagocytic Lymphohistiocytosis Emapalumab (NI-0501; Gamifant) Primary haemophagocytic lymphohistiocytosis (HLH) Genetic Disorders , Immunology 2018 View  |  Download
Etrolizumab for Crohn’s Disease Etrolizumab (PRO145223; RG7413; rhuMAb Beta7) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Filgotinib for treating moderately to severely active Crohn's disease Filgotinib (GLPG-0634; filgotinib maleate) Crohn's disease Gastroenterology , Immunology 2022 View  |  Download
Forigerimod plus Standard of Care for Systemic Lupus Erythematosus Forigerimod acitate (Lupuzor. IPP-201101; CEP-33457) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2018 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications